UK biotech Synairgen uses a protein called Interferon Beta to develop the new COVID-19 drug. Interferon Beta is produced by the human body when a viral infection is detected. Scientists expect that the study will also help other medical experts since there are currently few effective treatments that rely on patients' immune systems.
TechTimes
No comments:
Post a Comment